Targeting brain enzyme may offer new treatment for obesity

Endocannabinoids in the brain play a key role in food intake and energy use. Modulating the action of these molecules could help fight obesity, say researchers at Université de Montréal’s affiliated hospital research center.

M&A: Apixio and ClaimLogiq Merge to Minimize Reimbursement Inaccuracies

by Jasmine Pennic 06/15/2023 Leave a Comment What You Should Know: Apixio announced it has completed its merger with ClaimLogiq, a healthcare technology business that

June 15, 2023

Study advances understanding of complex neurological disorder

To effectively treat a disease or disorder, doctors must first know the root cause. Such is the case for developmental and epileptic encephalopathies (DEEs), whose

August 7, 2024

Vyne aims to raise $88M; Sanofi invests in gene therapy company; 4DMT addresses clinical hold

Plus, news about United Therapeutics and Moderna: Immuno-inflammation biotech’s $88M: Vyne Therapeutics announced an $88 million private placement to, in part, help fund a Phase

October 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.